-
Inclusion and exclusion criteria.
a World Bank (2012). Country and Lending Groups, Low and Lower Middle Income countries [cited August 29, 2013]; Available from:... -
r37980778c78--ce343bb5c2fe0d63e8978bffee4fa384
Clinical outcomes of pembrolizumab monotherapy according to PD-L1 expression level. -
manuscript_data
Data used in preparation of Figs 1F, 1G; 2E; 3B, 3C; 4D, 4E; 5C, 5E, 5G, 5I and 5K. (XLSX) -
Characteristics of study subjects.
JA-1, first-generation Japanese-Americans; JA-2, second- or later-generation Japanese-Americans; BMI, body mass index; BP, blood pressure; 2-h, two-hour post-load; HOMA-IR,... -
Characteristics of the study population.
SD = standard deviation; BMI = body mass index; BFP = Body fat percentage measured with bioelectrical impedance [24]; WHR = waist-hip ratio; HGS = handgrip strength, the highest... -
Logistic regression model.
Dependent variable: the occurrence of clinical combined outcomes (heart failure, stroke and total mortality) and independent variables: treatment (BZ), follow-up, male,... -
r37980778c78--ed42f962b029472c50d461e896cfa31c
Two-by-two confusion matrixes for SWMR (A) and conventional MRI (B). -
r37980778c78--12896ee4d2f85b30669235576a857573
Positive and negative results of IRIDICA PCR/electrospray ionization–mass spectrometry (PCR/ESI-MS) and culture of bronchoalveolar lavage in mechanically ventilated patients... -
Baseline data.
SSG = sodium stibogluconate (20 mg/kg/day for 30 days); PM = paromomycin sulphate (20 mg/kg/day for 21 days); SSG & PM Combination treatment (SSG at 20 mg/kg/day plus PM at 15... -
Changes in blood pressure for 1SD difference in baseline proximal and distal ...
Changes in blood pressure for 1SD difference in baseline proximal and distal fractional reabsorption of sodium (linear regression analysis). -
Characteristics of the study subjects.
All values except number of subjects, gender and smoking status are expressed as median values with minimum and maximum range in parentheses. Ex-smoker: stopped smoking for at... -
r37980778c78--5a7fbe536e9eb36b0c4909ea626334d4
BackgroundPembrolizumab is currently approved as a first-line therapy for advanced non-small cell lung cancer (NSCLC) patients with a programed death ligand-1 (PD-L1) expression... -
Clinical characteristics of patients.
Mean±SD [25., 50. und 75. percentile in case of non-normal distribution] or number (%). ap<0.05;bp<0.01;cp<0.005;dp<0.001 – comparison between survivors and... -
Relationships between outcomes and C-DL among 591 propensity-matched patients.
Relationships between outcomes and C-DL among 591 propensity-matched patients. -
Population characteristics.
Data are expressed as mean ± standard error or as percentages. Abbreviations: CRP: C-reactive protein, DAS28: disease activity score using 28 joint counts, DMARDs:... -
The sensitivity for the detection of pulmonary nodules and false positive dia...
The sensitivity for the detection of pulmonary nodules and false positive diagnoses of applied MRI sequences. -
Patient Characteristics.
Abbreviations: AML, acute myeloid leukemia; sAML, secondary AML; ALL, acute lymphoblastic leukemia; PMF, primary myelofibrosis; CLL: chronic lymphoblastic leukemia; SAA, severe...
